Assessing outcomes in liver disease patients: Reliability and validity of the Spanish version of the liver disease quality of life questionnaire (LDQOL 1.0)

Value in Health

Volumn 13, Issue 4, 2010, Pages 455-462

  Casanovas, Teresa ^a   Jané, Laia ^a   Herdman, Michael ^b,c,d   Casado, Alfonso ^e   Garcia, Beatriz ^a   Prat, Bibiana ^a   Fabregat, Joan ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Insight Consulting and Research   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e Dynamic Solutions   (Spain)

Author keywords

liver disease; quality of life; questionnaire; validity

Indexed keywords

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CONVERGENT VALIDITY; CRONBACH ALPHA COEFFICIENT; DEMOGRAPHY; DISCRIMINANT VALIDITY; FEASIBILITY STUDY; FEMALE; HEALTH SURVEY; HEPATITIS C; HUMAN; INTERNAL CONSISTENCY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER DISEASE QUALITY OF LIFE QUESTIONNAIRE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SEXUAL FUNCTION; SHORT FORM 36; SPAIN; VALIDITY; AGE; CROSS-SECTIONAL STUDY; HEALTH STATUS; HEPATIC INSUFFICIENCY; MIDDLE AGED; QUALITY OF LIFE; REPRODUCIBILITY; SEX DIFFERENCE; SOCIOECONOMICS; VALIDATION STUDY;

AGE FACTORS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HEPATIC INSUFFICIENCY; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEX FACTORS; SOCIOECONOMIC FACTORS; SPAIN;

EID: 77954290010     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2009.00688.x     Document Type: Article

References (37)

1. Younossi ZM, Guyatt G. Quality of life assessments and chronic liver disease. Am J Gastroenterol 1998 93 : 1037 1041.
2. Ratcliffe J, Longworth L, Young T, et al. Assessing health-related quality of life pre-and post-liver transplantation: a prospective multicenter study. Liver Transpl 2002 8 : 263 270.
3. Younossi ZM, McCormick M, Price LL, et al. Impact of liver transplantation on health-related quality of life. Liver Transpl 2000 6 : 779 783.
4. Casanovas T, Ramos E, Menchón JM, et al. Changes in quality of life after liver transplant. Impact of hepatitis C virus infection. Hepatology 1998 28 : A278.
5. Martin LM, Dan AA, Younossi ZM. Measurement of health-related quality of life in patients with chronic liver disease. Liver Transpl 2006 12 : 22 3.
6. Tome S, Wells JT, Said A, Lucey MR. Quality of life after liver transplantation. A systematic review. J Hepatol 2008 48 : 567 577.
7. Gralnek I, Hays RD, Kilbourne A, et al. Development and evaluation of the liver disease quality of life instrument in persons with advanced chronic liver disease - The LDQOL 1.0. Am J Gastroenterol 2000 95 : 3552 3565.
8. Younossi ZM, Guyatt G, Kiwi M, et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999 45 : 295 300.
9. Bayliss MS, Gandek B, Bungay KM, et al. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998 7 : 39 55.
10. Kanwal F, Spiegel BM, Hays RD, et al. Prospective validation of the short form liver disease quality of life instrument. Aliment Pharmacol Ther 2008 28 : 1088 1101.
11. Kanwal F, Gralnek IM, Hays RD, et al. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol 2009 7 : 793 799.
12. Casanovas T, Vallejo G, Herdman M, et al. Validation of the Spanish version of the liver disease quality of life questionnaire in transplant patients. Transplant Proc 2003 35 : 1803 1805.
13. Herdman M, Fox-Rushby J, Badía X. A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach. Qual Life Res 1998 7 : 323 335.
14. Deyo RA. Pitfalls in measuring the health status of Mexican Americans: comparative validity of the English and Spanish sickness impact profile. Am J Public Health 1984 74 : 569 573.
15. Kanwal F, Hays RD, Kilbourne AM, et al. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? Am J Gastroenterol 2004 99 : 1726 1732.
16. Ware JE Jr., Kosinski M, Dewey JE. How to Score Version 2 of the SF-36 Health Survey.
17. Casanovas Taltavull T, Vallejo Blanxart G, Herdman M, et al. Adaptación transcultural del cuestionario específico de calidad de vida para hepatopatías crónicas (LDQOL 1.0) para su uso en la población Española. Gastroenterol Hepatol 2003 26 : 234 244.
18. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed measures. J Clin Epidemiol 1993 46 : 1417 1432.
19. Alonso J, Prieto L, Antó JM. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clin (Barc) 1995 104 : 771 776.
20. Brown RS Jr., Kumar KS, Russo MW, et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002 8 : 278 284.
21. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001 33 : 464 470.
22. Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993 2 : 441 449.
23. Kondo Y, Yoshida H, Tateishi R, et al. Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. J Gastroenterol Hepatol 2007 22 : 197 203.
24. Iacobucci D, Duhachek A. Advancing alpha: measuring reliability with confidence. J Consum Psychol 2003 13 : 478 487.
25. Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959 56 : 81 105.
26. Ferrer M, Córdoba J, Garin O, et al. Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl 2006 12 : 95 104.
27. Bach N, Schaffner F, Kapelman B. Sexual behavior in women with nonalcoholic liver disease. Hepatology 1989 9 : 698 703.
28. Scientific Advisory Comittee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002 11 : 193 205.
29. Saab S, Ibrahim AB, Shpaner A, et al. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl 2005 11 : 218 223.
30. van der Plas SM, Hansen BE, de Boer JB, et al. Generic and disease-specific health related quality of life of liver patients with various aetiologies: a survey. Qual Life Res 2007 16 : 375 388.
31. Kallman J, O'neil MM, Larive B, et al. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci 2007 52 : 2531 2539. (Pubitemid 47373904)
32. Dias Teixeira MC, de Fatima Gomes de Sa Ribeiro M, Strauss E. A new insight into the differences among non-cirrhotic and cirrhotic patients using the liver disease quality of life instrument (LDQOL). Ann Hepatol 2005 4 : 264 271.
33. Zifroni A, Schiavi RC, Schaffner F. Sexual function and testosterone levels in men with nonalcoholic liver disease. Hepatology 1991 14 : 479 482.
34. Gomez-Lobo V, Burgansky A, Kim-Schluger L, Berkowitz R. Gynecologic symptoms and sexual function before and after liver transplantation. J Reprod Med 2006 51 : 457 462.
35. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989 10 : 407 415.
36. Figueras J, Jaurrieta E, Valls C, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997 25 : 1485 1489.
37. Fayers P, Machin D, eds. Quality of Life: The Assessment, Analysis, and Interpretation of Patient-reported Outcomes.